These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 20078610

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients.
    Li D, Lu W, Zhu JY, Gao J, Lou YQ, Zhang GL.
    J Clin Pharm Ther; 2007 Oct; 32(5):505-15. PubMed ID: 17875118
    [Abstract] [Full Text] [Related]

  • 23. Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers.
    Belmonte C, Ochoa D, Román M, Saiz-Rodríguez M, Wojnicz A, Gómez-Sánchez CI, Martín-Vílchez S, Abad-Santos F.
    Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):596-605. PubMed ID: 29325225
    [Abstract] [Full Text] [Related]

  • 24. The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.
    Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, Scott D, Gunes A, Dahl ML.
    JACC Cardiovasc Interv; 2008 Dec; 1(6):620-7. PubMed ID: 19463375
    [Abstract] [Full Text] [Related]

  • 25. Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation.
    Turolo S, Tirelli AS, Ferraresso M, Ghio L, Belingheri M, Groppali E, Torresani E, Edefonti A.
    Pharmacol Rep; 2010 Dec; 62(6):1159-69. PubMed ID: 21273673
    [Abstract] [Full Text] [Related]

  • 26. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.
    Han N, Yun HY, Hong JY, Kim IW, Ji E, Hong SH, Kim YS, Ha J, Shin WG, Oh JM.
    Eur J Clin Pharmacol; 2013 Jan; 69(1):53-63. PubMed ID: 22660440
    [Abstract] [Full Text] [Related]

  • 27. Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1.
    Yoo HD, Cho HY, Lee SN, Yoon H, Lee YB.
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):329-41. PubMed ID: 22623266
    [Abstract] [Full Text] [Related]

  • 28. CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.
    Santos PC, Soares RA, Santos DB, Nascimento RM, Coelho GL, Nicolau JC, Mill JG, Krieger JE, Pereira AC.
    BMC Med Genet; 2011 Jan 19; 12():13. PubMed ID: 21247447
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients.
    Namazi S, Kojuri J, Khalili A, Azarpira N.
    Biochem Pharmacol; 2012 Apr 01; 83(7):903-8. PubMed ID: 22265638
    [Abstract] [Full Text] [Related]

  • 34. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.
    Chen B, Shi HQ, Liu XX, Zhang WX, Lu JQ, Xu BM, Chen H.
    J Clin Pharm Ther; 2017 Dec 01; 42(6):679-688. PubMed ID: 28833329
    [Abstract] [Full Text] [Related]

  • 35. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.
    Zhou Q, Chen QX, Ruan ZR, Yuan H, Xu HM, Zeng S.
    Pharmazie; 2013 Mar 01; 68(3):187-94. PubMed ID: 23556337
    [Abstract] [Full Text] [Related]

  • 36. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
    Jun KR, Lee W, Jang MS, Chun S, Song GW, Park KT, Lee SG, Han DJ, Kang C, Cho DY, Kim JQ, Min WK.
    Transplantation; 2009 Apr 27; 87(8):1225-31. PubMed ID: 19384171
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation.
    Sy SK, Heuberger J, Shilbayeh S, Conrado DJ, Derendorf H.
    AAPS J; 2013 Oct 27; 15(4):1189-99. PubMed ID: 23990505
    [Abstract] [Full Text] [Related]

  • 39. Genetic variations in ABCB1 and CYP3A5 as well as sex influence quinine disposition among Ugandans.
    Mukonzo JK, Waako P, Ogwal-Okeng J, Gustafsson LL, Aklillu E.
    Ther Drug Monit; 2010 Jun 27; 32(3):346-52. PubMed ID: 20357698
    [Abstract] [Full Text] [Related]

  • 40. The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
    Chew SC, Singh O, Chen X, Ramasamy RD, Kulkarni T, Lee EJ, Tan EH, Lim WT, Chowbay B.
    Cancer Chemother Pharmacol; 2011 Jun 27; 67(6):1471-8. PubMed ID: 21468756
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.